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With introduction of the 2009 pandemic H1N1 virus (pH1N1) into swine herds, 
reassortment between the pH1N1 and endemic swine influenza viruses (SIVs) has been 
reported worldwide. Recently, reassortant H3N2 and H1N2 variant SIVs that contain the 
M gene from pH1N1 virus and the remaining seven genes from North American triple-
reassortant (TR) SIVs have emerged. These variant viruses have caused more than 300 
cases of human infections and one death in the USA, creating a major public health 
concern. To date, the pathogenicity and transmissibility of H1N2 variant viruses in pigs 
has not been investigated. Through passive surveillance, we have isolated two genotypes 
of reassortant H1N2 viruses with pH1N1 genes from diseased pigs in Kansas. Full 
genome sequence and phylogenetic analysis showed that one is a swine H1N2 variant 
virus (swH1N2v) with the M gene from pH1N1; the other is a reassortant H1N2 virus 
(2+6 rH1N2) with six internal genes from pH1N1 and the two surface genes from 
endemic North American TR H1N2 SIVs. Furthermore, we determined the pathogenicity 
and transmissibility of the swH1N2v, a human H1N2 variant (huH1N2v), and the 2+6 
rH1N2 in pigs using an endemic TR H1N2 SIV (eH1N2) isolated in 2011 as a control. 
All four viruses were able to infect pigs and replicate in the lungs. Both H1N2 variant 
viruses caused more severe lung lesions in infected pigs when compared to the eH1N2 
and 2+6 rH1N2 viruses. Although all four viruses are transmissible in pigs and were 
detected in the lungs of contact animals, the swH1N2v shed more efficiently than the 
other three viruses in the respective sentinel animals. The huH1N2v displayed delayed 
and inefficient nasal shedding in sentinel animals. Taken together, the human and swine 
H1N2 variant viruses are more pathogenic and the swH1N2v more transmissible in pigs 
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Chapter 1 - Influenza Virus Literature Review 
 Introduction 
Influenza, commonly known as flu, is an infectious zoonotic disease caused by 
negative sense, single-stranded RNA viruses of the Orthomyxoviridae family which are 
able to infect a variety of species including birds, ferrets, cats, pigs, and humans 1. In 
water fowl, the disease is largely asymptomatic and primarily affects the gastrointestinal 
tract while poultry can develop disease of variable severity. In swine, the virus can cause 
high morbidity resulting in substantial economic losses for the pork industry and even 
food shortages for local and national municipalities. In humans, the virus causes a 
contagious respiratory disease of variable severity that can lead to death 2. 
Although every person is at risk for the flu, the CDC identifies persons at high-
risk for flu-related complications as children under the age of five, adults 65 years and 
older, pregnant women, and people with underlying medical conditions such as asthma or 
heart disease. Despite the development and wide use of vaccines, it is estimated that 
500,000 persons die annually from the flu during non-pandemic years 3. In pandemic 
years, the death toll can climb to millions like the 1918 “Spanish Flu” which killed 
upwards of 50 million people worldwide 4.  
 Orthomyxoviridae Family of Viruses 
There are five RNA viruses in the Orthomyxoviridae family of viruses: Influenza 
A Virus, Influenza B Virus, Influenza C Virus, Isavirus, and Thogotovirus. As the names 
suggest, Influenza A, Influenza B, and Influenza C viruses cause influenza 2; however, 
their host range and severity of infection varies widely between genera. Influenza A 
viruses (IAVs) are the most predominant of the three genera, infecting both birds and 
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mammals, and consists of numerous subtypes based on the combination of its surface 
proteins, hemagglutinin (HA) and neuraminidase (NA) 5. Additionally, IAVs change 
more rapidly than influenza B and C viruses which is why they are responsible for all 
pandemics to date including the 1918 Spanish flu, 1957 Asian flu, 1968 Hong Kong flu, 
and the 2009 swine flu 6,7. 
Influenza B viruses cause severe disease and are responsible for annual epidemics 
in humans which is why they are included in the annually produced trivalent seasonal 
influenza vaccine. However, they change much slower than IAVs and their host range is 
largely restricted to humans with only occasional infections in seals 8. On the other hand, 
influenza C viruses are only found in pigs and humans where they cause a mild upper 
respiratory illness without pandemic potential and are therefore not included in vaccine 
therapy 9. 
 Influenza A Virus 
 Morphology 
The IAV can vary greatly in size and shape, from small spherical morphologies of 
only 80-120 nanometers (nm) in length to long, filamentous particles measuring several 
micrometers (μm) in length 10,11. It is thought that smaller droplets (less than 1 μm in 
length) travel further in aerosols and are therefore more transmissible than larger droplets 
(larger than 6 μm) which travel only a few meters. Although most human IAVs are 
filamentous in structure, continual passages in eggs or tissue cultures leads to a more 
spherical formation 12,13 which results in higher titers and possibly more efficient 
transmission 14,15. Host cell type and actin cytoskeleton have also been shown to play a 
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role in influenza morphology with the formation of filamentous morphologies best seen 
in polarized epithelial cells 16. 
 Virus Genome and Structure 
The IAV is a negative-sense, single-stranded RNA virus consisting of eight RNA 
segments that encode for 12-16 proteins 17. These segments are labeled according to size 
with segment one being largest and segment eight being smallest. Segments one, two, and 
three encode for the polymerase basic 2 (PB2), polymerase basic 1 (PB1), and 
polymerase acidic (PA) proteins, respectively. Collectively, these three proteins comprise 
the polymerase complex. Segment two also encodes two additional proteins in some 
viruses: the pro-apoptotic virulence factor named PB1-F2 which is translated via an 
alternative open reading frame (ORF) 18 and the N40 protein for which there is no well-
defined role via an in-frame downstream initiation site 19. Segment three also encodes for 
an additional protein named PA-X that is involved in shutoff of host protein synthesis via 
a ribosomal frame-shift during translation. Segment four encodes the HA protein 
responsible for cellular receptor binding. Segment five encodes the nucleoprotein (NP) 
which is bound to the viral RNAs (vRNAs) and carries nuclear localization signals 
(NLSs). Segment six encodes the sialic-acid cleaving transmembrane NA protein. 
Segment seven encodes both the multifunctional matrix one (M1) protein which supports 
the structure of the virus and the matrix two (M2) protein that functions as an ion 
channel. Segment eight encodes both the host antiviral response antagonist non-structural 
protein 1 (NS1) and the nuclear export protein (NEP), formerly known as non-structural 
protein 2 (NS2). 
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The viral lipid envelope is derived from the host plasma membrane and contains a 
lipid bilayer comprised of transmembrane proteins HA and NA as well as the ion channel 
M2 20. HA and NA are similar in that they both protrude from the surface of the influenza 
virion as “spikes,” are major targets for the host humoral response, and are bound to the 
viral envelope by a short sequence of hydrophobic amino acids; however, they are 
structurally different. The HA protein is rod-shaped and much more prevalent than NA 
which is mushroom-shaped 21,22. 
The ion channel M2 is also present in the membrane and is involved with un-
coating the virus during entry 23 as well as dissociating the vRNPs from M1 during the 
early phase of the infectious cycle 20. The remaining proteins are enclosed within the M1 
protein which supports the morphology of the virion 24. Enclosed within the M1 proteins 
are the NEPs and the RNP complex. The RNP complex, also known as the virion core, is 
required for  viral replication and transcription 25 and consists of the viral RNA bound by 
NP and the RNA-dependent RNA polymerase complex 23,26,27. 
 Viral Proteins 
 Surface Proteins Hemagglutinin and Neuraminidase 
The HA protein is critical for virus entry and fusion within the endosome. 
Infectivity is dependent on cleavage of the HA0 precursor by furin into the mature 
HA1/HA2 form. The HA1 contains the sialic acid binding domain and HA2 contains the 
fusion peptide. Cleavage of HA0 is a prerequisite for the conformational change to the 
low pH after which the fusion peptide is hidden preventing new virions from aggregating 
and losing infectivity 28.  
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It is believed that HA evades antibody recognition by antigenic shift 29 with 
mutations in the N-linked glycosylation thought to alter the oligosaccharide layer 
surrounding HA 30. Truncation of the HA protein can lead to a change in virion 
morphology which can affect transmissibility 31-33. Several antigenic and species-specific 
phylogenetically important regions (PIRs) have been identified in HA. PIRs for human-
like H1 viruses include 96A, 133S, and 183P 34. Additionally, putative antigenic sites 
have been identified including 91Y, 134A, 180H, and 225G 34,35 with mutation G225D/E 
playing a role in altering viral receptor specificity during adaptation of avian influenza 
viruses (AIVs) to pigs 36-39.  
The NA is found as a tetramer on the surface of the host-derived lipid envelope 
and functions to cleave the sialic acid containing receptors to allow for the release of 
progeny virions from infected cell surfaces 23,40. NA contains a large number of highly 
conserved, charged residues in the pocket enclosing the sialic acid binding sites and 
around its rim including 118R, 119E, 151N, 152R, 198N, 224R, 227E, 243N, 274H, 
276E, 277E, 292R, 330N, 350K, and 425E. It is thought that these amino acids are in 
locations where they are either 1) inaccessible to antibodies, 2) accessible to antibodies 
but only in such a way that non-essential amino acids also form the antigen-antibody 
complex, or 3) are not antigenic 41. Three human-like PIRs have been detected as 51M, 
331S, and 403R 34 with mutations M51I, S331R, and R403M suspected to play a role in 
adaptation of viruses containing human-like N2s to swine 42. 
It is important for the HA and NA activities to be balanced in order for productive 
rounds of infection to be maintained 43. Although NA is not required by the virus to infect 
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cells, antibodies to NA do mitigate the disease resulting in lower pulmonary viral titers 
and less severe lung lesions 41,44.   
 Matrix and Non-structural Proteins 
The M1 protein forms the majority of the virion and has several known functions 
associated with viral assembly and budding 23. In fact, expression of M1 alone can lead to 
budding of viral vesicles from the plasma membrane 45,46. It accumulates at the plasma 
membrane interacting with the cytoplasmic tails of HA and NA and is thought to initiate 
bud formation by inducing membrane curvature 14,32,47,48. This was demonstrated by 
inducing mutations in the cytoplasmic tails of HA and NA and deletions in M2 which 
exhibited reduced incorporation of M1 and vRNPs and reduced the stability of progeny 
virions 14,32,49,50. Additionally, increased viral-like particle (VLP) formation was observed 
by association of membrane targeting peptide to M1 suggesting that the plasma 
membrane-M1 association is critical for VLP formation 51.  
M1 also plays a role in virion morphology 24 and assembly through interactions 
with HA, NA, M2, and vRNPs 52. It is believed that a long filamentous virion may have 
the potential for increased cell-to-cell transmission in the respiratory mucous by infecting 
neighboring cells prior to even being released 16. On the other hand, small spherical cells 
are likely to be more easily incorporated into aerosols and thus, to transmit more 
efficiently 10. Bourmakina et al first demonstrated the importance of M1 in determining 
virion morphology by replacing the spherical forming M1 of A/WSN/33 with the 
filamentous forming M1 of A/Udorn/72 which resulted in a filamentous formation. They 
found that mutations R95K in the amino-terminal and E204N in the carboy-terminal 
regions of M1 resulted in a significant reduction in filamentous formation. This suggested 
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that these regions play an important role in determining filamentous or spherical viral 
morphology 10. 
While some studies have shown that mutation A41V in M1 resulted in loss of 
filamentous particle formation 53-55, another study showed that V41A had no effect on 
formation but that mutation K95R abrogated filamentous particle formation 10. Position 
95 is important because it is on the surface of the molecule and amino acid changes can 
affect the charge which in turn can affect its interactions with other cellular components 
10,56-58. Additional sites suspected to play a role in virion morphology include amino acids 
30, 102, 204, 207, 209, and 218 10,14,31,54. M1-M1 interaction has also been shown to be a 
determinant of virion morphology because M1 forms a helical net under the viral 
membrane and the pitch of the helical turn of the M1 protein differs between spherical 
and filamentous virion formation 59. 
The NS1 protein has been shown to inhibit host IFN-α and IFN-β synthesis 60. In 
fact, the NS1 of the 1918 H1N1 IAV increased the pathogenicity of the virus by inducing 
numerous pro-inflammatory chemokine and cytokine genes which in turn attracted pro-
inflammatory innate immune cells. It also down-regulated the expression of IFN-
stimulated genes decreasing the host’s immune response 61. It also appears to play a role 
but does not seem to be required for host protein shutoff 62. Moreover, it is involved with 
nuclear export and stability of cellular mRNA and enhances the efficiency of viral 
mRNA translation 63-65. 
The NEP protein was originally named non-structural 2 protein because it was 
thought to have no function in the virion. However, studies have proven that it is 
involved in exporting vRNPs from the nucleus for packaging into new virions. It is also 
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thought to support viral budding and to regulate the accumulation of viral mRNA, cRNA, 
and vRNA66. 
 RNP Complex Proteins 
The RNP complex consists of the PB2, PB1, PA and NP proteins and has long 
been known to be important in determining host specificity 67. For instance, amino acid 
changes at position 627 have been identified as important for AIV replication competence 
in mammalian cells. It has been shown that avian 627E restricts viral growth in humans 
and monkeys but that a mutation to lysine can restore viral replication 68. However, it was 
recently discovered that 627K is not required for efficient infection or induction of 
disease in mammals. This is demonstrated by the fact that equine and swine IAVs possess 
amino acid 627E, the same as is found in HPAI H5N1 69-72. Additionally, one study 
showed that residues 627E in conjunction with 701N function similarly to the E627K 
mutation 73. Other amino acid changes in the PB2 protein have been shown to be 
important in adapting AIVs to mammals. Amino acids residues 271 and 588 have been 
shown to improve polymerase activity 74 while amino acid 701 has been shown to 
increase polymerase activity of HPAI in mammals 75. Additionally, phenylalanine at 
position 636 has been shown to improve polymerase activity in mammals 69.  
The PB1 protein has been shown to be important for pathogenicity. For example, 
other than HA and NA it was the only gene segment to be exchanged in the 1957 and 
1968 pandemics 76,77. Additionally, this protein from the 1918 H1N1 virus was shown to 
be required for full pathogenicity of the virus in mice 78.  
The PB1-F2 protein is a 99 amino acid protein translated from alternative 
initiation of PB1 and is thought to initiate host cell apoptosis by targeting mitochondria 
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18. It initiates apoptosis by permeating the mitochondria resulting in the dissipation of the 
mitochondrial membrane and causing the release of cytochrome c 79,80. It is also thought 
to suppress the adaptive immune response by decreasing antigen presentation 76. This has 
been shown by the decreased presence of lymphocytes and impaired immune response 
seen in humans infected with HPAIs 76,81. It also acts to delay viral clearance and prolong 
viral replication by impairing CD8+ T cells (those responsible for viral clearance) leading 
to the development of irreversible pulmonary immunopathology 82,83. Moreover, studies 
have shown that HPAIs in which PB1-F2 was knocked out resulted in decreased 
pathogenicity in mice 84.  
The c-terminal domain of PB1-F2 is significant for mitochondrial targeting and 
contains five species-specific signatures 85,86. Specifically, position 66 is in the α-helical 
domain and mutation N66S is thought to have a pro-apoptotic function 76. This is because 
N66S causes a significant increase in IFN-γ and TNF-α causing a cytokine dysregulation 
similar to that of 1918 H1N1 and HPAI H5N1 81,87. N66S is also thought to increase 
apoptosis by affecting interactions with ANT3 and VDAC1 80. 
The PA protein is believed to be a multi-functional protein though its exact roles 
have not been well defined. Studies have shown that it is involved with both replication 
and transcription. Mutation T97I has been shown to play a role in adapting AIVs to 
mammals and increasing virulence in a mouse model 88.  
Compared to other ORFs, NP displays distinct boundaries between human and 
avian species-specific amino acids. Several of these are located in regions that interact 
with cellular proteins and play a role in antiviral mechanisms of host cells. Notably, 
amino acid 313 is highly conserved between species with human viruses possessing 
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tyrosine (Y), avian and swine viruses possessing phenylalanine (F), and 2009 pandemic 
H1N1 viruses possessing valine (V) 89,90. 
 Replication 
 Virus Attachment 
The HA protein is the major envelope protein of IAV and forms a projection-like 
spike on the surface of the virion that elicits neutralizing antibodies 91. It enables the virus 
to attach to host cells by binding the N-acetylneuraminic (sialic) acid expressed on the 
surface of many host cells in many species. This sialic acid terminal binds to either 
carbon-3 or carbon-6 galactose through its carbon-2 resulting in two conformations: α-2, 
3 and α-2, 6 linkages 92. Accordingly, the HA of different strains of IAVs will 
preferentially bind either the α-2, 3 or α-2, 6 linkages. 
Most avian and equine IAVs bind the sialic acid α-2, 3 linkage while human and 
swine IAVs preferentially bind the sialic acid α-2, 6 linkages 93. In poultry, the α-2, 3 
linkages are predominantly expressed in the gastrointestinal tract. In humans, the α-2, 6 
linkages are predominantly expressed in the upper respiratory tract while some α-2, 3 
linkages are also be expressed in the lower respiratory tract. This may explain why 
humans can be infected with AIVs, albeit rarely. It may also explain the high 
pathogenicity seen in humans infected with AIVs. 
Swine also possess both α-2, 3 and α -2, 6 receptors in their respiratory tract, 
similar to that in humans, 94 which allows them to be infected with human, swine, and 
avian influenza viruses and is why they are considered the “mixing vessels” for IAVs 95. 
Further supporting the “mixing vessel” hypothesis is the fact that reassortant SIVs 
containing genes from swine, avian, and human IAVs have been isolated from pigs which 
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can then transmit to humans 96. Furthermore, at least 1-13 HA subtypes of AIVs are able 
to infect and replicate in pigs 97. This has led to the belief that many AIVs gain adaptation 
to mammals via swine. 
 Virus Entry 
After the virus attaches to host cells, it enters the cell via receptor-mediated 
endocytosis. Once encapsulated, the virus is translocated toward the nucleus. 
Concurrently, the hydrogen ions within the endosome drive the pH down to 
approximately five which aids in un-coating the virus and the subsequent release of 
vRNPs into the cytoplasm 98. The exact mechanism for this acidification and release of 
vRNPs occurs in a few of steps. First, the low pH in the endosome creates a 
conformational change in the HA0 which exposes a fusion peptide (HA2) that mediates 
the fusion of the viral envelope with the host membrane. This in turn opens a pore in the 
endosome that allows the vRNPs to be released into the cytoplasm. However, prior to the 
membrane fusion, the hydrogen ions from the endosome enter the virus via the M2 ion 
channel and disrupt the M1 matrix proteins polymerization and interaction with the viral 
RNPs. This then allows the vRNPs to be released into the cytoplasm 99. Once released 
from the virion, vRNPs and viral proteins are imported into the nucleus via NLSs in the 
NP 99. 
 Synthesis of Viral RNA 
Once inside the nucleus, the viral RNA-dependent RNA polymerase is 
responsible for unprimed replication of vRNAs and initiates viral mRNA synthesis by 
“cap snatching” in which the PB2 subunit binds the 5’ cap of host pre-mRNAs. The 
RNA-dependent RNA polymerase uses the negative-sense vRNA as a template to 
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synthesize positive-sense mRNAs and cRNAs. The mRNAs serve as a template for viral 
proteins synthesis while the cRNA is transcribed into more copies of negative-sense 
vRNA. The NPs are required for these steps of replication and are deposited on the cRNA 
and vRNA during RNA synthesis. This is unique to influenza viruses because most other 
single-stranded RNA viruses are not replicated or transcribed in the nucleus 100. After 
transcription, the endonuclease domain of the PA subunit then cleaves the cap. From 
there, viral mRNAs are transported to the cytoplasm for translation into viral proteins 
mediated by an M1-NS2 complex that is bound to the vRNPs. The NS2 interacts with the 
human chromosome maintenance region 1 protein that exports the vRNPs from the 
nucleus 100. 
 Synthesis of Viral Proteins and Assembly 
In the early stage of infection, the polymerase subunits PB2, PB1, and PA are 
translated in the cytoplasm using vRNA as a template and are then transported back to 
the nucleus via NLSs. Some of the M1 proteins are transported back to the nucleus while 
the NEP proteins re-enter the nucleus via free diffusion 99. During the late stage of 
infection, surface proteins HA, NA, and M2 are synthesized on membrane-bound 
proteins in the endoplasmic reticulum and glycosylated in the Golgi apparatus before 
being transported to the cell membrane. The remaining proteins are transported back into 
the nucleus for formation of more vRNPs for the new virus particle 100. 
Once sufficient viral proteins have been produced, the virus begins the assembly 
process. Although the process is not fully understood, there are two proposed 
mechanisms for viral assembly: 1) the random packaging model and 2) the specific 
packaging model. The random packaging model suggests that the viral segments will be 
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randomly packaged into the virions while the specific packaging model suggests that 
viral segments will be selectively packed into virions by signals from each RNA segment 
101. 
 Virus Budding and Release 
The vRNPs translocate to the cell membrane where they bind to the terminal 
sialic acids of the HA and NA proteins and clump together. The NA of the newly formed 
viruses then cleaves the sialic acid residues from cell surface glycoproteins and 
gangliosides, allowing for the release of the progeny virus from the infected cell 100. The 
new virus can then infect neighboring cells or be transmitted to another host. 
 Antigenic Drift and Antigenic Shift 
IAVs can undergo a number of changes in their genomes via two mechanisms: 
antigenic drift and antigenic shift. Antigenic drift is the result of gradual accumulations in 
point mutations caused by lack of proofreading of the RNA-dependent RNA polymerase 
during viral replication. Antigenic drift is responsible for currently circulating seasonal 
influenza viruses which cause epidemics in humans. Since 1968, most severe epidemics 
have been the result of the H3N2 IAVs 2. 
Antigenic shift is an abrupt change in the subtypes of a host species and occurs 
via one of three mechanisms: 1) genetic reassortment, 2) direct transfer of an entire virus 
from one host species into another species, and 3) the re-emergence of a virus that was 
previously seen in a species but is no longer endemic. Genetic reassortment occurs when 
two or more different influenza viruses (parent strains) simultaneously infect a cell and 
yield new viruses (progeny viruses) with genes from different parent strains. Genetic 
reassortment between different strains can result in the emergence of a new strain and 
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new subtype. Additionally, genetic reassortment between avian, equine, canine, swine, 
and human IAVs can lead to the emergence of hybrid viruses 2. The end result of 
antigenic shifts is often a novel influenza virus capable of evading the immune systems 
thereby leading to an epidemic or a pandemic as was seen in 1918, 1957, 1968, and 2009 
2. 
 Influenza A Virus Ecology 
Given the relative frequency of IAV epidemics and pandemics, much research has 
been done to investigate the pathogenicity of virus and host factors in the transmissibility 
and pathogenicity of IAVs. The use of reverse genetics has helped to study the role of 
each viral protein while the use of different animal models including mice, ferrets, pigs, 
and rhesus macaque monkeys has led to an understanding of the roles of these viruses in 
different animals 17,102. Recent pandemics and the advances in detection have placed 
more and more emphasis on the continual surveillance and reporting of IAVs to 
authorities 2. 
 Avian Influenza A Viruses 
While waterfowl and shorebirds are the natural reservoirs for most IAVs, 
infections in these birds are largely asymptomatic. However, infections of poultry with 
IAVs can cause avian influenza. AIVs are divided into low pathogenic avian influenza 
(LPAI) viruses and high pathogenic avian influenza (HPAI) viruses based on the genetic 
features of the virus and the severity of disease in birds. LPAI viruses begin shedding 
within 1-2 days of infection and continue shedding for 1-2 weeks. In contrast, HPAI 
viruses can be shed for up to 30 days. To date, only the H5 and H7 subtypes have caused 
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HPAI while all other HA subtypes have caused LPAI 2. However, the H1-H16 subtypes 
have been isolated from waterfowl 103. 
In wild birds, a large amount of virus is shed in the feces and the virus is primarily 
spread via the fecal-oral route. Adding to the transmissibility is the fact that AIVs are 
relatively stable in the environment and have been detected in waters where ducks swim. 
In poultry, the virus can quickly spread through the flock via both the fecal-oral route in 
addition to aerosols transmission due to the proximity of the birds. Recently, isolates of 
HPAI H5N1 have been detected in higher quantities from tracheal samples than from 
fecal samples of chickens suggesting that the fecal-oral route may no longer be the 
primary route of infection. AIVs can also spread via vectors such as flies, fomites, 
migratory birds, and even cracked eggs infected with the virus 2. 
 Human Influenza A Viruses 
In humans, H1N1 viruses related to the 1918 H1N1 pandemic circulated alone 
until the 1957 pandemic introduced H2N2 viruses which circulated until 1968. These 
viruses continued with antigenic drift away from the 1918 H1N1 104,105. In 1977, the 
H1N1 viruses from the 1950s reemerged 91 and led to more reassortment which led to 
substantial further antigenic evolution of the human H1N1 viruses 106. There are currently 
three endemic subtypes of viruses: H1N1, H1N2, and H3N2. The H1N2 virus was first 
detected in humans in 2001 and is most likely the result of genetic reassortment between 
H1N1 and H3N2 human IAVs. 
Humans infected with IAVs usually begin shedding the virus 3-4 days after 
infection and about 1-2 days before the onset of symptoms. The virus is transmitted in 
two ways: 1) aerosols produced by sneezing and coughing and 2) direct contact with 
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nasal discharge or fomites exposed to nasal discharge. In general, close contact and 
closed environments enhance transmission. Unlike AIVs, mammalian IAVs are relatively 
unstable and do not survive well in the environment outside of dried mucus 2. 
In humans, the seasonal influenza virus transmits very efficiently and causes 
mostly mild cases of flu. In contrast, the HPAI H5N1 virus has demonstrated very limited 
human-to-human transmission but causes severe pneumonia that can result in systematic 
infection and multiple organ failure. Other IAVs that infect humans cause a wide range of 
disease, ranging from mild to severe, often depending on host factors including age and 
health conditions 2.  
 Swine Influenza A Viruses 
SIVs cause an acute respiratory disease in pigs and play an important role in 
porcine respiratory disease complex. It has also been associated with outbreaks of 
abortions on swine farms 107-109. Although mortality is usually low, less than 1%, 
morbidity can be as high as 100%. Additionally, SIVs can transmit within a herd quickly 
causing pigs to become ill and experience clinical signs of lethargy, fever, dyspnea, 
cough, and oculonasal discharge for 5-10 days 110-112. Most pigs begin shedding within 24 
hours of infection and continue to shed for 7-10 days 2. Additionally, there is evidence to 
suggest that piglets play a more important role than sows in maintaining influenza 
infections, transmission, and persistence 112. 
Classical H1N1 SIV (cH1N1) was first isolated from swine in the US in 1930 112 
and is antigenically similar to a reconstructed 1918 H1N1 virus 104. The cH1N1 remained 
antigenically stable and was exclusively prevalent in North American swine populations 
until 1998 when it reassorted with both a human H3N2 virus and an American-lineage 
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AIV of unknown origin which resulted in a triple-reassortant (TR) H3N2 SIV 108-110,113-
115. This TR H3N2 virus contains genes of human- (PB1, HA, NA), swine- (NP, M, NS), 
and avian-lineage (PB2, PA) influenza viruses. The prevalence of this constellation of 
internal genes (human-lineage PB1, swine-lineage NP, M, and NS, and avian-lineage 
PB2 and PA) has warranted the name “triple-reassortant internal gene” (TRIG) cassette 
110. Interestingly, TRIG readily accepts different HA and NA combinations leading to an 
increase in the generation of reassortant IAVs 42,96. As a result, several reassortant viruses 
including H1N1, H1N2, H3N1, and H3N2 viruses been detected in swine herds in the US 
116,117.  
Three types of H1 viruses have been detected in US swine populations: classical 
H1N1, TR H1N1 which contains HA and NA from cH1N1 and TRIG from H3N2, and 
human-like H1N1 and H1N2 viruses that contain human-like HA and NA and TRIG 
from TR SIVs 42. Based on phylogenetic analysis, there are four H1 phylogenetic clusters 
detected in swine in the US: α (classical swine), β (reassortant H1N1-like), γ (H1N2-
like), and δ (human-like H1). In addition to the clades above, there are two sub-clusters 
of the H1 δ clade that are from independent introductions of human seasonal HA into 
SIVs: δ-1 and δ-2 35. Human-like H1 SIVs were first detected in Canada in 2004 118 and 
in the US in 2005 42. Until 1998 there was much cross-reactivity between H1; however, 
there is little H1 cross-reactivity between these four clades 42,117.  
The H1N2 SIV is one of the major subtypes of IAVs circulating in swine herds 
worldwide. Different H1N2 SIVs have become established and maintained in North 
American and Eurasian swine populations 119. The H1N2 viruses isolated from pigs in 
North America are typically triple-reassortant viruses containing human-, swine- and 
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avian-origin IAVs 119.  In the United States, the H1N2 virus is a reassortant virus 
containing genes from cH1N1, human-like H1N1, and TR H3N2 viruses and has 
increased in prevalence ever since.  
The Eurasian swine H1N2 viruses are double-reassortant viruses between avian-
like H1N1 and human H3N2 viruses 120. H1N2 SIVs were first isolated from pigs 
Sweden in the winter of 2008-2009 121. In Japan and France, H1N2 SIVs were the result 
of reassortment between cH1N1 and human H3N2 viruses in pigs 107. In the United 
Kingdom, multiple reassortment events are suspected between human H1N1 and H3N2 
which generated a novel reassortant H1N2 virus that in turn acquired all six internal 
genes from a wholly avian H1N1 virus 95,107. 
Although the H1N2 virus has not caused disease any more severe in pigs than that 
of other subtypes of IAVs, a TR H1N2 SIV has been detected in mink on a 15,000-head 
mink farm in the Midwest United States 122, showing that the swine H1N2 virus is able to 
cross the species barriers. 
 2009 Pandemic H1N1 “Swine Flu” 
The 2009 pandemic H1N1 (pH1N1) emerged in April 2009 and spread to more 
than 70 countries in less than two months. Shortly thereafter the virus was detected in 
more than 200 countries causing the World Health Organization (WHO) to declare it a 
pandemic 123. According to WHO, there were between 43 and 89 million cases of 
infection with pH1N1 from April 2009 to April 2010 resulting in 195,000 – 403,000 
hospitalizations and 8,870 – 18,300 confirmed deaths worldwide, though these numbers 
are thought to be conservative. The virus has since been detected from a variety of other 
species including swine, turkeys, ferrets, and cats 1. The virus was dubbed “Swine Flu” 
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because it is antigenically most related to cH1N1 and North American TR H1N1 SIVs 
that have circulated in the US for more than 10 years and have sporadically caused 
human infections 114,124. However, there are many genetic and antigenic distinctions 
between pH1N1 and SIVs 125.  
Sequence analysis revealed that pH1N1 was the result of multiple reassortments 
and contains a unique constellation of genes 114. The HA, NP, and NS genes are from 
cH1N1 that entered swine around 1918 and continued to circulate in cH1N1 and TR SIVs 
126. The NA and M genes are of Eurasian swine-lineage that entered the Eurasian swine 
population from avian source in 1979 127 and continued to circulate exclusively in Eurasia 
128. The PB1 gene is from TR swine-lineage and was transmitted from humans around 
1998, though it was originally transmitted from an avian source to humans in 1968 77. 
Finally, the PB2 and PA genes are of TR swine-lineage that first entered North American 
swine from avian in 1998 109. Interestingly, six of the eight genes in pH1N1 are found in 
North American TR SIVs and despite their longtime establishment in swine, have shown 
limited human-to-human transmission, rarely causing human infections 14,114,129,130. 
The Eurasian-lineage NA and M genes are thought to enhance the spread of 
pH1N1 and has been demonstrated in ferret studies 131. Specifically, the Eurasian-lineage 
NA is thought to exhibit higher neuraminidase activity in vivo and may increase 
enzymatic activity causing the release of more viral particles resulting in enhanced 
transmission 14. Susceptibility of pigs to pH1N1 was shown experimentally 36,132,133 after 
outbreaks of pH1N1 in pigs were detected in 2009 in which direct human-to-pig 
transmission was suspected 34,134,135. Since then, pH1N1 has become established in North 
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American swine herds based on genetic analysis of more than 1,500 SIVs isolated 
between 2009 and 2010 136.  
 Reassortant SIVs with Genes from pH1N1 Detected Worldwide 
The first reassortment of endemic SIVs and pH1N1 was detected in Hong Kong 
in 2010. In this case the virus possessed pH1N1-lineage NA, Eurasian-lineage HA, and 
TRIG 86. Since then, reassortant viruses between SIVs and pH1N1 have been detected 
worldwide.  In England, a reassortant virus with European H1N2 SIV-derived HA and 
NA and the other six genes from pH1N1 was detected 137. In Italy, a reassortant virus was 
isolated that possessed all pH1N1-derived genes except for an H1N2 SIV-derived NA 138. 
In Thailand, a reassortant H1N1 virus was detected with all pH1N1-derived genes except 
for an endemic H1N1 SIV-derived NA 139. In Argentina, an outbreak of pH1N1 in swine 
led to the detection of two reassortant H1N1 SIVs that possessed human-like SIV-derived 
HA and NA and all remaining genes from pH1N1 134. 
 Reassortant SIVs with Genes from pH1N1 Detected in the United States 
In the US, reassortant SIVs representing several distinct genotypes of pH1N1 and 
SIVs have been identified including TR H1N2 and H3N2 subtype SIVs 86. Most of these 
viruses possess HA and NA genes of currently circulating SIVs and all contain the M 
gene from pH1N1 suggesting that this is a favorable constellation 106. Viruses that have 
been reported to cross the species barrier to infect humans and are known as “variant” 
viruses 137. However, testing of both human and swine isolates of H3N2 variant (H3N2v) 
viruses in ferret and swine models showed no increased pathogenicity or transmissibility 
compared to the endemic SIVs 122,140. Other reassortant viruses between pH1N1 and 
H3N2 SIVs containing 3-5 internal genes from pH1N1 have been identified 1. 
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Novel reassortant H1N2 viruses with genes from pH1N1 virus have also been 
isolated from swine in Europe 122,137 and North America 140. Recently, the novel TR 
H1N2 variant (H1N2v) viruses with only M gene from pH1N1 have been reported to 
infect humans in Minnesota (www.WHO.int). In fact, there were two cases of children 
infected with a swine variant IAV after being exposed to pigs at a state fair although no 
further human-to-human transmission was reported. 
 Zoonosis 
Although waterfowl are the natural reservoirs for most IAVs 91, interspecies 
transmission of IAVs has been well documented despite the detection of host-range 
restrictions 134,141-146. Evidence of zoonotic transmission of IAVs from pigs to humans has 
been especially well documented 107,147-150. According to the CDC, from December 2005 
– November 2010, there were more than 300 human infections with variant SIVs in the 
US including H1N1v, H1N2v, and H3N2v viruses 151. Then, in 2011 an H3N2v virus 
with pH1N1 M gene and the remaining genes from endemic H3N2 SIVs emerged and 
caused 12 human infections (mostly in children) in Indiana, Maine, Pennsylvania, Iowa, 
Utah and West Virginia. Also in 2011, an H1N2v virus with pH1N1 M gene infected a 
child at a state fair. There were 12 more confirmed cases of humans infected with H3N2v 
viruses in 2011 and an alarming 309 cases in 2012 152,153. This has raised public health 
concerns that the introduction of human IAVs into swine could generate novel reassortant 
viruses that spill back into the human population 96. 
 Purpose of Research 
The H1N2v virus has been reported to infect humans in the US though no further 
human-to-human transmission has been reported. To our knowledge, H1N2 viruses with 
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genes from pH1N1 virus isolated from swine have not been characterized in animal 
models. This demonstrates the importance of understanding the virulence and 
transmissibility of these novel reassortant H1N2v viruses in the event that a more virulent 
and transmissible reassortant virus emerges, which might pose significant economic and 
socio-economic threats to the swine industry and public health. In this study we 
characterized H1N2v viruses isolated from human and swine in vitro and in vivo 
compared with a reassortant H1N2 virus containing genes from pH1N1 using an endemic 
H1N2 virus as a control. 
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Chapter 2 - Materials and Methods 
 Cells 
Madin-Darby canine kidney (MDCK) cells were cultured in Eagle’s minimum 
essential medium (MEM) containing 5% fetal bovine serum (FBS) (Fischer Scientific, 
Houston, TX), 1% antibiotics (Invitrogen, Carlsbad, CA), 1% L-glutamine (Invitrogen, 
Carlsbad, CA), and 1% 1x MEM vitamins (Invitrogen, Carlsbad, CA). Human alveolar 
basal epithelial (A549) cells and porcine kidney (PK-15) cells were grown in Dulbecco’s 
modified Eagle medium (DMEM) with 10% FBS, 1% antibiotics, 1% L-glutamine, and 
1% 1x MEM vitamins. Cells were inoculated with viruses using infecting MEM prepared 
by adding 0.3% BSA (Sigma), 1 µg tosyl phenylalanyl chloromethyl ketone-treated 
trypsin (TPCK Trypsin) (Sigma, St. Louis, MO), 1% antibiotics, L-glutamine, and 1x 
MEM vitamins to MEM. All cells were incubated at 37oC with 5% CO2. 
 Viruses 
One novel reassortant H1N2 SIV with six internal genes from pH1N1 and two 
H1N2v viruses, one swine and one human variant with M gene from pH1N1, were 
characterized in this study using an endemic TR H1N2 SIV isolated in 2011 as a control. 
The reassortant A/swine/Kansas/12-117893/2012 (2+6 rH1N2) with PB2, PB1, PA, NP, 
NS, and M genes from pH1N1 was isolated from nasal swabs of a four-week old weaned 
pig with fever, coughing, and depression in a nursery with high morbidity and 
approximately 5% mortality. The swine variant A/swine/Kansas/12-156064/2012 
(swH1N2v) with M gene from pH1N1 was isolated from nasal swabs of a gilt with 
depression, dyspnea, and nasal discharge. The endemic A/swine/Kansas/11-104259/2011 
(eH1N2) with all genes from North American TR SIVs was isolated from a 28-day old 
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pig with a history of streptococcal infections but no physical symptoms of illness and 
served as a control in this study. These samples were submitted for diagnostic testing to 
the Kansas State Virology Diagnostic Laboratory (KSVDL) in Manhattan, KS where they 
were initially identified as IAVs by reverse-transcription (RT) polymerase chain reaction 
(PCR) before being transferred to Dr. Wenjun Ma’s laboratory for further 
characterization. The human variant virus A/Minnesota/14/2012 (huH1N2v) was isolated 
from a human and kindly provided by the Centers for Disease Control and Prevention 
(CDC).  
 Hemagglutinin Inhibition Assay 
Hemagglutinin inhibition (HI) assays were completed using sera of all direct-
infection pigs prior to infection 42. For this, sera was first heat-inactivated at 56⁰C, then 
treated with a 20% suspension of kaolin (Sigma Aldrich, St. Louis, MO) in order to 
eliminate non-specific inhibitors, and lastly absorbed with 0.5% chicken red blood cells. 
To confirm that sera was negative for SIVs, the HI assay was performed to test antibodies 
against a panel of reference SIV strains including A/swine/Iowa/1973 H1N1, 
A/swine/Texas/1998 H3N2, and A/swine/North Carolina/2001 H1N1v. 
 Molecular Characterization 
Each virus was first amplified in MDCK cells to create sufficient working stocks 
for further characterization. Viral RNA was extracted from MDCK cell culture 
supernatants using the QIAamp Viral RNA Mini Kit (Qiagen, Hilden, Germany). Viral 
cDNAs of each gene segment were obtained by RT using vRNA as templates and a 
universal influenza (Uni12) primer. Each gene was amplified by PCR using a respective 
segment-specific primer. The amplified full-length gene products were separated onto 
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agarose gel and purified using the Qiaquick Gel Extraction Kit (Qiagen Inc., Valencia, 
CA, USA). The RT-PCR products were sequenced using specific sequencing primers and 
full genomes were sequenced (sequence primers are available upon request). Sequences 
were analyzed using the Lasergene sequencing analysis software (DNASTAR, Madison, 
WI) and BLAST (http://blast.ncbi.nlm.nih.gov) to determine virus subtype. Sequences 
were aligned using CLUSTAL W and phylogenetic tree analyses were generated with 
1,000 bootstrap replicates using MegAlign software (version 4.1). Amino acid mutations 
were identified using MEGA software (version 5.1). 
 Titrations 
Viral titrations of cell culture supernatants, bronchoalveolar lavage fluid (BALF), 
and nasal swab samples were performed in quadruplicate using 96-well plates of 
confluent MDCK cells maintained as previously described. Serial dilutions for each 
sample were completed from 10-1 to 10-8 using infecting MEM and then 100 µl of each 
dilution was added to MEM-washed confluent MDCK cells in each well. Cells were 
incubated at 37⁰C with 5.0% CO2 and evaluated for cytopathogenic effect (CPE) at 24- 
and 48-hours post-infection (hpi). At 72-hpi, plates were fixed in methanol and 
immunocytochemically stained with a monoclonal antibody specific to influenza NP. 
For this, plates previously fixed for 10 minutes with methanol were washed three 
times with washing solution consistent of 0.05% Tween in PBS. Then, 50 µl of MAb-anti 
Influenza A virus nucleoprotein (ATCC #HB-65; H16-L10-4R5) diluted 1:500 in diluting 
solution consistent of 0.05% Tween in PBS plus 1.0% BSA was added to each well and 
allowed to incubate at room temperature for 30 minutes. Plates were then washed three 
times in washing solution. Next, 50 µl of rabbit anti-mouse IgG conjugated HRP (DAKO 
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catalog #P0260) diluted 1:300 in diluting solution was added to each well and allowed to 
incubate at room temperature for 30 minutes. Plates were again washed three times in 
washing solution. Next, 50 µl of AEC substrate prepared by adding 19 mL of AEC 
diluent (0.1M acetic acid plus 5.75 ml glacial acetic acid plus 1 liter of ddH20) plus 1 ml 
AEC solution (400 mg AEC plus 100 ml dimethylformamide mixed in a chemical fume 
hood) plus 20 µl H2O2 was added to each well and allowed to incubate for 30 minutes 
until a red color change was evident. Finally, plates were rinsed thoroughly with water 
and allowed to air dry before reading under a microscope. 
 Real-time RT-PCR for M gene of pH1N1 
A previously published real-time RT-PCR assay was employed in this study to 
detect the presence of the pH1N1 M gene from nasal swabs of contact-exposure pigs in 
the swH1N2v and huH1N2v groups154. In this assay, the primers and probes were 
designed specifically for targeting the pH1N1 M gene (Table 2-1). RNA was extracted 
from nasal swab samples and a known pH1N1 virus (positive control) using the QIAamp 
viral RNA kit (Qiagen, Valencia, CA, USA). This assay was performed on a Smart 
Cycler using a Qiagen One-Step RT-PCR master mix prepared as follows: 5 µl of 5X 
buffer, 2µl of dNTP (10mm), 0.625µl of forward primer (20µm), 0.625 µl of reverse 
primer (20µm), 0.25 µl of probe (10 µm), 0.2 µl of BSA (25 µg/µl), 2.5 µl of MgCl2 
(50mm), 0.25 µl of RNAse inhibitor (10 U/µl), 1 µl of enzyme mix, 5.55 µl of RNAse-
free water, and 8 µl of sample template. A total of 8 µl sample from negative-control pigs 
was used as a negative control. The Smart Cycler thermocycling conditions was 
programmed as follows: 50ºC for 30 minutes, 95ºC for 15 minutes, then 40 cycles of 
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94ºC for 15 seconds and 60ºC for one minute. Cutoff for this assay was set at 35 
threshold cycles (Ct). 
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Table 2-1 Primers and probe used for the one-step real-time RT-PCR assay. 
   Primers/Probe       Location of Primers* Amplicon (bp) 
 
Real-time RT-PCR Pan-M-Probe: 5’- TTG CATGGG CCT CAT ATA CAA C-3’  ---------   92 
 
pH1N1 specific  Pan-M-F: 5’- GGT GTC ACT AAG CTA TTC AA-3’  342-361   --------- 
 
   Pan-M-R: 5’- CAA AAG CAG CTT CTG TGG TC-3’  414-433   --------- 
Table 2-1 Location of primers was calculated based on the ORF of the Matrix 1 gene. This table used with permission of the original 
authors.
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 Plaque Assay 
Viral dose and the size of plaques formed by each virus was measured by 
traditional plaque assay. For this, 10-fold serial dilutions were made for each virus using 
infecting MEM. One milliliter of each dilution was inoculated onto a confluent 
monolayer of MDCK cells in six-well plates and allowed to incubate for 60 minutes at 
37oC with 5% CO2. Medium was removed from each well and cells were washed with 
fresh (unaltered) MEM. After removing the fresh MEM, 3mL of an MEM, 1% agarose, 
and 1µg/mL TPCK Trypsin mixture was added to each well and allowed to set at 4⁰C for 
10 minutes until gel solidified. Plates were then incubated in an inverted position for 72 
hours at 37oC with 5% CO2. Gels were carefully removed from each well and cells fixed 
with methanol for 10 minutes. Cells were then stained with 0.5% crystal violet dye in 
PBS for 15 minutes at room temperature before gently rinsing with a slow stream of cool 
water and allowed to air-dry. 
 Replication Kinetics 
Viral replication kinetics were performed for all viruses on monolayers of MDCK 
(MOI 0.001), A549 (MOI 0.01) and PK-15 (MOI 0.01) cells in 12-well plates at the 
indicated multiplicity of infection (MOI). Viral samples were collected at 0-, 12-, 24-, 36-
, and 48- hpi, centrifuged at 1,200 rpm for five minutes to remove cellular contents, and 
stored at -20⁰C. Samples were titrated in quadruplicate onto confluent MDCK cells in 96-
well plates. CPE was visualized at 48-hpi and cells were fixed with methanol for 10 
minutes at 72-hpi. Immunocytochemistry test (ICC) was performed using the monoclonal 
NP antibody to confirm CPE. Viral titer (TCID50/mL) was calculated for each sample by 
the method of Reed and Meunch. 
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 Animal Ethics Statement 
All animal studies were conducted at the Large Animal Research Center (LARC) 
at Kansas State University (KSU), a facility accredited by the Association for Assessment 
and Accreditation of Laboratory Animal Care International (AAALAC). All procedures 
were approved by the Institutional Animal Care and Use Committee (IACUC) and 
performed under the guidance of two experienced large animal research veterinarians. 
 Pig Study 
A total of 45 healthy four- to five-week old outbred pigs from an SIV-negative 
and porcine reproductive and respiratory syndrome virus-negative farm in Texas were 
randomly divided into direct-infection, contact-exposure, and negative-control groups: 
four direct-infection groups consistent of six pigs each, four contact-exposure groups 
consistent of four pigs each, and one negative-control group consistent of five pigs. 
Direct-infection pigs were anesthetized on day zero using telazol and xylazine and 
inoculated intra-tracheally with 1.5mL of 105 TCID50/mL of each virus. Four naïve 
contact animals were added to each direct-infection group at 2-days post-infection (dpi) 
and allowed to comingle freely to assess virus transmission. Pigs were observed for 
clinical signs of infection and body temperatures were recorded daily. Three pigs from 
each direct-infection group and two negative-control pigs were euthanized at 5-dpi by 
administering FATAL-PLUS intravenously at a dosage of 1mL/10 lbs. of body weight. 
The remaining direct-infection and negative-control pigs as well as all contact-exposure 
pigs were euthanized at 7-dpi and 5-days post-contact (dpc). 
Nasal swabs were collected from all direct-infection pigs at 0-, 3-, 5-, and 7-dpi 
and from contact pigs at 0-, 1-, 3-, and 5-dpc. Blood samples were collected from each 
31 
pig at day 0 and on necropsy days. Macroscopic lung lesions were evaluated by a single, 
experienced research veterinarian and scored based as a percentage of each lung lobe 
with lesions. BALF samples were collected from all lungs by flushing lungs with 50 mL 
of MEM. BALF and nasal swab samples were titrated onto MDCK cells to determine 
viral titers as previously described 116. Lung lobes were collected and fixed in 10% 
formalin during necropsy before staining with haemotoxylin and eosin for 
histopathological examination. Anti-influenza A mAb against NP was used for 
immunohistochemistry (IHC) staining. Lung samples were examined blindly by a 
veterinary pathologist and scored on a scale of 0-3 based on severity of bronchial 
epithelial injury 155. 
 Statistical Analysis 
Statistics are shown as the mean and the standard error for each mean. Viral titers, 
macroscopic lung lesions, and microscopic lung lesions were analyzed by student’s t-test. 
A p-value ≤ 0.05 was considered significant. 
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Chapter 3 - Results 
 Subtyping and Molecular Analysis of eH1N2, 2+6 rH1N2, swH1N2v, 
and huH1N2v 
The three Kansas swine isolates were identified as H1N2 viruses by nucleotide 
sequencing and a BLAST search of the National Library of Medicine 
(http://blast.ncbi.nlm.nih.gov). Full genome sequences for each virus were deposited into 
Genbank and can be found using the following accession numbers: eH1N2 (KJ528280-
KJ528287), 2+6 rH1N2 (KJ528288-KJ528295), swH1N2v (KJ528296-KJ528303), and 
huH1N2v (KJ620412-KJ620419). 
 Molecular Analysis of the Hemagglutinin and Neuraminidase Molecules 
The HA molecules of all viruses clustered into the δ-1 sub-cluster (human-like H1 
clade) based on phylogenetic analysis (Figure 3-1) and contain a total of 566 amino acids. 
Molecular comparison of the HA molecules revealed that eH1N2, 2+6 rH1N2, and 
huH1N2v all share 99% identity at the nucleotide level and 98-99% identity at the amino 
acid level. In contrast, swH1N2v was different sharing only 96% identity at the 
nucleotide level and 95-96% identity at the amino acid level with the other three viruses. 
Amino acid differences were identified between the HA molecules of all viruses, 
especially between swH1N2v and the other three viruses (Table 3-1). The receptor 
binding sites of all viruses are similar and contain human seasonal H1N1/pH1N1 amino 
acid residues 155G, 158N, 190T, 219K, 223Q, 224E, 225G, and 230I 156. Similarly, the 
cleavage sites of these viruses are highly homologous with human seasonal and swine 
H1N1 viruses. The PIRs of all viruses are similar including residues 96A, 133S, and 
183P [183S in swH1N2v], all of which are common to North American TR H1N2 
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viruses, human seasonal viruses, and pH1N1 viruses34,42,157,158. Additionally, the putative 
antigenic sites of all viruses contain the human-like amino acid residues 91Y, 134A, 
180H, 187N (187D in swH1N2v), and 225G which support preference for α-2, 6 sialic 
acid binding 156,159.  
The NA molecules of all viruses clustered into the American TR, recent-human 
clade (Figure 3-2) and consist of 470 amino acids. The NA molecules of eH1N2, 2+6 
rH1N2, and huH1N2v were very similar sharing 99% identity at the nucleotide level and 
98-99% identity at the amino acid level. However, the swH1N2v was different, sharing 
only 95% homology at both the nucleotide and amino acid levels with the other three 
viruses. Notably, eH1N2, 2+6 rH1N2, and huH1N2v all differed by five or fewer amino 
acids while swH1N2v differed by 22 amino acids (Table 3-1). Interestingly, the PIRs of 
all viruses contain the human-like amino acids 51M, 331S, and 403R instead of the 
proposed M51I, S331R, and R403M mutations thought to support introduction into swine 
42,157. 
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Figure 3-1 Phylogenetic tree of HA molecules. 
 
Figure 3-1 Phylogenetic tree of the HA molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in five clades: the α clade has closest homology to 
classical swine viruses, the β clade has closest homology to reassortant H1N1-like 
viruses, the γ clade has closest homology to H1N2-like viruses, the pH1N1 clade has 
closest homology to pH1N1 viruses, and the δ clade has closest homology to human-like 
H1 viruses as indicated by the bars on the right of the tree. Phylogenetic trees were 
generated with 1,000 bootstrap replicates using MegAlign software (version 4.1).  
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Figure 3-2 Phylogenetic tree of NA molecules. 
 
Figure 3-2 Phylogenetic tree of the NA molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in three clades: the American triple-reassortant clade, 
the European swine clade, and the Eurasian Avian clade as indicated by the bars on the 
right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates using 




Table 3-1 Amino acid differences between the HA and NA molecules of the 
swH1N2v and huH1N2v viruses. 
 
Protein Position swH1N2v huH1N2v  Protein Position swH1N2v
 huH1N2v 
HA 24 I  T   NA 41 D  N 
26 L  F    50 V  A 
32 A  T    60 K  R 
33 H  Y    71 I  T 
108 E  K    126 P  T 
119 S  P    147 D  N 
120 D  E    149 I  V 
127 Q  E    176 I  M 
161 V  A    236 T  A 
164 V  E    257 I  V 
174 G  K    262 V  I 
202 G  E    267 T  K 
215 S  P    284 S  F 
217 G  E    309 D  N 
218 D  N    310 H  Y 
240 R  G    312 V  I 
276 T  A    329 N  S 
309 A  S    332 F  V 
342 T  A    336 H  Y 
483 N  S    344 E  K 
512 R  K    367 D  N 
522 S  Y    369 D  T 
552 A  V    370 S  L 
- -  -    386 P  A 
- -  -    390 S  L 
- -  -    402 N  D 
Table 3-1 List of amino acid differences between the HA and NA molecules for 
swH1N2v and huH1N2v. The HA protein is numbered according to the H1 numbering 
system. There are 23 unique amino acid differences between the HA molecules 
accounting for approximately 5% of the total amino acids. There are 26 unique amino 
acid differences between the NA proteins accounting for approximately 5.5% of the total 
amino acids. 
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 Molecular Analysis of Matrix and Non-Structural Molecules 
The M molecules of the 2+6 rH1N2, swH1N2v, and huH1N2v viruses clustered 
into the pH1N1 clade while eH1N2 clustered into the North American TR swine clade 
(Figure 3-3). The M1 molecules of all four viruses contain 238 amino acids. Molecular 
comparison of the M1 molecules shows that the 2+6 rH1N2, swH1N2v, and huH1N2v 
molecules share 99% homology at the nucleotide and amino acid levels. In contrast, the 
eH1N2 shared 86-87% homology at the nucleotide level and 94% homology at the amino 
acid level. 
The M1 molecules of all viruses contain amino acids residues 41A, 102K, and 
204E 54 which contribute to a filamentous virion morphology; however, viruses with 
pH1N1 M gene contain unique amino acid differences that contribute to a more spherical 
virion morphology. These amino acid residues include 30S (30N in huH1N2v) (Table 
3-2), 31A, 95R, 142A, 207N, 209T, and 218T which are thought to increase transmission 
of pH1N1 10,14,31. Additionally, the avian/swine signature 137T was found in all viruses. 
Viruses with pH1N1 M gene contain avian signatures 115V and 121T while eH1N2 
contains human signatures 115I and 121A 89.  
The M2 molecules of all viruses contain 98 amino acids. Similar to the M1 
molecules, the M2 molecules of 2+6 rH1N2, swH1N2v, and huH1N2v all shared 99% 
homology at the nucleotide and amino acid levels. However, the eH1N2 differed, sharing 
only 91-92% homology at the nucleotide level and 86-87% homology at the amino acid 
level. Notably, only four substitutes were identified between viruses with the pH1N1 M 
gene and A/California/04/2009 (pH1N1) (Table 3-2): S13N in 2+6 rH1N2, D24N in 
swH1N2v, P25S in swH1N2v, and V27A (associated with amantadine resistance) in both 
variant viruses. Another mutation associated with amantadine resistance, S31N, was also 
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found in all viruses with the pH1N1 M gene. Avian/swine signatures were identified in 
all viruses at residues 57Y, 86V, and 93N as well as in viruses with pH1N1 M gene at 
residues 11T and 20S. In contrast, eH1N2 contained two human signatures, 11I and 20N 
89. 
The NS molecules of eH1N2, swH1N2v, and huH1N2v all clustered into the 
North American TR swine clade while 2+6 rH1N2 clustered in the pH1N1 clade (Figure 
3-4). The NS1 molecules of all viruses contain 220 amino acids with considerable 
variation. The NS1 molecules of eH1N2 and swH1N2v were highly homologous sharing 
99% identity at the nucleotide level and 98% identity at the amino acid level. The 
huH1N2 shared 96% identity at the nucleotide level and 95% identity at the amino acid 
level with both the eH1N2 and swH1N2v viruses. Predictably, identity between the 2+6 
rH1N2 and the other three viruses was considerably lower, sharing only 92-94% identity 
at the nucleotide level and 91-92% at the amino acid level. Notably, both variant viruses 
differed by 10 amino acids (Table 3-2).  
The NS2 molecules of all viruses contain 122 amino acids. As with the NS1 
molecules, the eH1N2 and swH1N2v viruses were most similar, sharing 99% identity at 
the nucleotide level and 98% identity at the amino acid level. The huH1N2 shared 97% 
identity at the nucleotide level and 95-97% identity at the amino acid level with both the 
eH1N2 and swH1N2v viruses. Predictably, identity between the 2+6 rH1N2 and the other 
three viruses was considerably lower, sharing only 93-94% identity at the nucleotide 
level and 93-95% identity at the amino acid level. All viruses possess the avian/swine 
signature 107L and amino acid residue 70G, both of which are present in pH1N1 viruses 
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70,89. Only five amino acid differences were identified between swH1N2v and huH1N2v 
(Table 3-2). 
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Figure 3-3 Phylogenetic tree of M molecules. 
 
Figure 3-3 Phylogenetic tree of the M molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
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Figure 3-4 Phylogenetic tree of NS molecules. 
 
Figure 3-4 Phylogenetic tree of the NS molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
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Table 3-2 Amino acid differences between the M1, M2, NS1, and NS2 molecules of 
the swH1N2v and huH1N2v viruses. 
Protein Position swH1N2v huH1N2v  Protein Position swH1N2v
 huH1N2v 
M1 30 S  N   NS1 6 M  V 
M2 24 N  D    45 G  R 
25 P  S    51 G  S 
NS2 6 M  V    70 R  K 
 11 D  G    84 V  I 
15 R  K    90 I  L 
16 Q  R    119 M  I 
19 I  T    124 M  I 
- -  -    139 S  N 
- -  -    178 V  I  
Table 3-2 List of amino acid differences between the M1, M2, NS1, and NS2 molecules 
of swH1N2v and huH1N2v. There is only one unique amino acid difference between the 
M1 molecules accounting for 0.42% of the total amino acids. There are two unique amino 
acid differences between the M2 molecules accounting for approximately 2.0% of the 
total amino acids. There are 10 unique amino acid differences between the NS1 
molecules accounting for approximately 4.5% of the total amino acids. There are five 
unique amino acids between the NS2 molecules accounting for 3.3% of the total amino 
acids. 
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 Molecular Analysis of the Polymerase Complex (PB2, PB1 [PB1-F2], PA [PA-
X]) and NP Molecules 
The polymerase complex molecules PB2, PB1, PA, and NP of eH1N2, swH1N2v, 
and huH1N2v clustered into the North American TR swine clade while 2+6 rH1N2 
clustered into the pH1N1 clade (Figure 3-5, Figure 3-6, Figure 3-7, Figure 3-8). 
The PB2 molecules of all viruses contain 760 amino acids. The eH1N2, 
swH1N2v, and huH1N2v viruses shared 98-99% identity at the nucleotide level and 99% 
homology at the amino acid level. In contrast, the 2+6 rH1N2 virus differed from the 
other three viruses, sharing only 93-94% identity at the nucleotide level and 97% at the 
amino acid level. The PB2 molecules of all viruses possess the same host-range-specific 
residues 271A, 588T, 627E, 636L, and 701D 69. Avian/swine signatures were identified 
in all viruses at residues 44A, 199A, 475L, 567D, 588T, 613V, 627E, 674A, and 702K 
while a single human signature was identified at 271A 89,160. Although the viruses in this 
study possess avian-adapted residue 627E instead of mammalian-adapted 627K, it has 
been reported that mutations found in these viruses including L89V, T271A, G309D, 
T339K, R477G, I495V, G590S, Q591R, and 676T act in lieu of the E627K mutation to 
support adaptation to replication in mammals by changing the electrostatic charge on the 
surface of residue 627 from negative to positive 69,160,161. A total of seven distinct amino 
acids were identified between swH1N2v and huH1N2v (Table 3-3). 
The PB1 molecules of all viruses contain 758 amino acids and showed 
considerable variation. The eH1N2 and swH1N2v viruses were most similar, sharing 
97% identity at the nucleotide level and 99% at the amino acid level while 2+6 rH1N2 
and swH1N2v were least similar, sharing only 93% identity at the nucleotide level and 
97% identity at the amino acid level. Comparison of the other viruses showed 94-95% 
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identity at the nucleotide level and 97-98% identity at the amino acid level. Two genetic 
signatures were identified in viruses with pH1N1 M gene: avian/swine signature 327R 
and human signature 336I, both of which are present in pH1N1 viruses 89. A total of 14 
amino acid differences were identified between swH1N2v and huH1N2v (Table 3-3). 
Analysis of the PB1-F2 molecules revealed that the eH1N2, swH1N2v, and 
huH1N2v viruses possess a full-length PB1-F2 ORF encoding 80 amino acids while 2+6 
rH1N2 is truncated and possesses only 12 amino acids, consistent with pH1N1 viruses. 
The eH1N2 and swH1N2v viruses share 99% identity at the nucleotide level and 97% 
identity at the amino acid level. In contrast, the huH1N2v virus shares 95% and 96% 
identity at the nucleotide level with the eH1N2 and swH1N2v viruses, respectively. 
Moreover, it shares only 89% and 86% identity at the amino acid level with the eH1N2 
and swH1N2v viruses. There are 11 unique amino acid differences between swH1N2v 
and huH1N2v (Table 3-3). While these viruses lack the N66S mutation found in the 
Hong Kong 1997 H5N1 78 and 1918 pandemic viruses which is thought to increase 
virulence, they do possess mutations E6D, R53K, and R75H which are thought to 
increase pathogenicity 77. 
The PA molecules of all viruses contain 717 amino acids. The eH1N2, swH1N2v, 
and huH1N2v viruses all shared 98-99% identity at the nucleotide level and 99% identity 
at the amino acid level. However, the 2+6 rH1N2 virus differed from the other three 
viruses, sharing only 93-94% identity at the nucleotide level and 96-97% identity at the 
amino acid level. Avian/swine genomic signatures (also present in pH1N1 viruses) were 
found in all viruses at residues 55D, 225S, 268L, 404A, 409N, and 552T 89. Human 
genomic signatures were identified at 57Q in swH1N2v and 356R in 2+6 rH1N2 while a 
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single human genomic signature (also present in pH1N1 viruses) was identified in all 
viruses at 409N. Interestingly, all viruses retained amino acid residue 97T instead of 97I 
which is thought to play a role in the adaptation of influenza viruses to mammalian hosts 
88. A total of six amino acid differences were identified between swH1N2v and huH1N2v 
(Table 3-3). 
The PA-X molecules of all viruses contain 233 amino acids. The eH1N2, 
swH1N2v, and huH1N2v viruses all share 99% identity at both the nucleotide and amino 
acid levels. In contrast, the 2+6 rH1N2 virus differed from the other three viruses, sharing 
only 92% identity at the nucleotide level and 93-94% identity at the amino acid level. The 
swH1N2v virus possesses only two unique amino acid, E209G and A212E, while the 
huH1N2v virus possesses only one unique amino acid difference, V100I. 
The NP proteins of all viruses contain 499 amino acids. The eH1N2, swH1N2v 
and huH1N2v viruses shared 98-99% identity at the nucleotide level and 99% identity at 
the amino acid level. However, the 2+6 rH1N2 virus differed significantly, sharing only 
92-93% identity at the nucleotide level and 94% identity at the amino acid level with the 
other three viruses. Avian/swine genomic signatures (also present in pH1N1 viruses) 
were identified in all viruses at 16G, 61I, 109I (eH1N2, swH1N2v, huH1N2v), 214R, 
283L, 293R, 305K, 372E, 422R, 442T, and 445D. Human genomic signatures (also 
present in pH1N1 viruses) were found in all viruses at 100V (eH1N2, swH1N2v, 
huH1N2v), 33I, 305K, and 357K89. Additionally, all viruses contain amino acid residue 
53E while 2+6 rH1N2 contained amino acid mutations G34A and I109T, all of which are 
thought to help incorporate the pH1N1 M gene into the TRIG cassette 34,162. Only four 
amino acid differences were identified between swH1N2v and huH1N2v (Table 3-3). 
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Figure 3-5 Phylogenetic tree of PB2 molecules. 
 
Figure 3-5 Phylogenetic tree of the PB2 molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
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Figure 3-6 Phylogenetic tree of PB1 molecules. 
 
Figure 3-6 Phylogenetic tree of the PB1 molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
48 
Figure 3-7 Phylogenetic tree of PA molecules. 
 
Figure 3-7 Phylogenetic tree of the PA clades based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
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Figure 3-8 Phylogenetic tree of NP molecules. 
 
Figure 3-8 Phylogenetic tree of the NP molecules based on nucleotide sequences from 
eH1N2 (blue diamond), 2+6 rH1N2 (red diamond), swH1N2v (green diamond), and 
huH1N2v (purple diamond) and other sequences from GenBank. The phylogenetic tree 
shows the relationship of viruses in seven clades: the triple-reassortant swine clade, the 
classical swine clade, the human seasonal clade, the American avian clade, the Eurasian 
Avian clade, the Eurasian swine clade, and the pH1N1 clade as indicated by the bars on 
the right of the tree. Phylogenetic trees were generated with 1,000 bootstrap replicates 
using MegAlign software (version 4.1).  
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Table 3-3 Amino acid differences between the PB2, PB1, PB1-F2, PA, PA-X, and NP 
molecules of the swH1N2v and huH1N2v viruses. 
Protein Position swH1N2v huH1N2v Protein Position swH1N2  huH1N2v 
PB2 456 S  N  PB1-F2 4 E  G 
 480 V  I   27 I  T 
 543 E  K   36 I  T 
 556 N  H   37 L  R 
 559 S  T   40 D  G 
 560 L  V   43 P  L 
 607 L  F   50 G  D 
PB1 4 N  H   56 V  A 
 111 M  H   67 P  L 
 140 A  S   68 T  I 
 171 M  I   79 Q  R 
 212 V  M   80 STOP  STOP 
 223 A  T  PA 100 V  I 
 374 S  A   469 F  L 
 433 R  K   547 E  D 
 435 T  V   614 N  D 
 517 I  V   626 K  R 
 581 N  D   628 M  V 
 587 A  V  NP 125 N  S 
 618 E  D   217 V  I 
 642 S  N   353 L  I 
PA-X 100 V  I   400 R  K 
 209 E  G   - -  - 
 212 A  E   - -  - 
Table 3-3 List of amino acid differences between swH1N2v and huH1N2v. There are 
seven unique amino acid differences between the PB2 molecules accounting for less than 
1.0% of the total amino acids. There are 14 unique amino acid differences between the 
PB1 molecules accounting for approximately 1.8% of the total amino acids. There are six 
unique amino acid differences between the PA molecules accounting for less than 1.0% 
of the total amino acids. There are four unique amino acids between the NP molecules 
accounting less than 1.0% of the total amino acids. There are three unique amino acid 
differences between the PA-X molecules accounting for 1.2% of the total amino acids. 
There are 11 unique amino acid differences between the PB1-F2 molecules accounting 
for 18.75% of those amino acids. 
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 Origin of Each Gene Segment 
Molecular analysis of each virus revealed that all gene segments from eH1N2 
have closest homology to endemic North American TR SIVs. Similarly, all genes from 
both variant viruses share highest homology to North American TR SIVs with exception 
of the matrix gene which has highest homology to pH1N1 viruses. Dissimilarly, all 
internal gene segments from the 2+6 rH1N2 virus share highest homology with pH1N1 
viruses while only its surface proteins, HA and NA, have highest homology with North 
American TR SIVs (Table 3-4).  
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Table 3-4 Virus subtype and origin of each gene from eH1N2, 2+6 rH1N2, 
swH1N2v, and huH1N2v. 
Virus  Subtype PB2 PB1 PA HA NP NA M NS 
eH1N2 H1N2  T T T T T T T T 
2+6 rH1N2  H1N2  P P P T P T P P  
swH1N2v  H1N2  T T T T T T P T  
huH1N2v  H1N2  T T T T T T P T 
Table 3-4 Genes denoted with ‘T’ have closest homology with North American triple-
reassortant swine influenza viruses. Genes denoted with ‘P’ have closest homology with 
the 2009 pandemic H1N1 virus. 
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 In Vitro Studies 
 Plaque Assay 
Plaque assays showed that swH1N2v and huH1N2v formed large, similar-sized 
plaques compared to eH1N2 and 2+6 rH1N2 which formed small, similar-sized plaques 
at 72-hpi in MDCK cells (Figure 3-9). 
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Figure 3-9 Viral plaque assay on MDCK cells. 
 
Figure 3-9 Plaque assays for each virus on MDCK cells at 72-hpi. MDCK cells infected 
with each virus at MOI 0.001. All viruses formed plaques; however, both variant viruses 
formed significantly larger plaques than the eH1N2 and 2+6 rH1N2 viurses. 
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 Viral Replication Kinetics 
Growth studies showed that all viruses replicated efficiently in PK-15, A549, and 
MDCK cells. In PK-15 cells, the huH1N2v virus grew to significantly higher titers than 
the other three viruses at 24-, 36- and 48-hpi (Figure 3-10). In A549 cells, the huH1N2v 
virus grew to significantly higher titers than the other three viruses at 24-hpi. By 36-hpi, 
the 2+6 rH1N2 and huH1N2v viruses grew to significantly higher titers than the 
swH1N2v virus which grew to significantly higher titers than the eH1N2 virus. By 48-
hpi, the 2+6 rH1N2, swH1N2v, and huH1N2v viruses all grew to similar titers which 
were significantly higher than the eH1N2 virus (Figure 3-11). In MDCK cells, the 2+6 
rH1N2 virus grew to significantly higher titers than the other three viruses at 24- and 36-
hpi while all viruses grew to similar titers by 48-hpi (Figure 3-12). 
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Figure 3-10 Viral replication kinetics in PK-15 cells. 
 
Figure 3-10 Viral replication kinetics for eH1N2 (blue), 2+6 rH1N2 (red), swH1N2v 
(green), and huH1N2v (purple) viruses in PK-15 (porcine kidney) cells. * represents p-
value of < 0.05. 
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Figure 3-11 Viral replication kinetics in A549 cells. 
 
Figure 3-11 Viral replication kinetics for eH1N2 (blue), 2+6 rH1N2 (red), swH1N2v 
(green), and huH1N2v (purple) viruses in A549 (human adenocarcinomic basal 
epithelial) cells. * represents p-value of < 0.05. 
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Figure 3-12 Viral replication kinetics in MDCK cells. 
 
Figure 3-12 Viral replication kinetics for eH1N2 (blue), 2+6 rH1N2 (red), swH1N2v 
(green), and huH1N2v (purple) viruses in MDCK (Madin-Darby canine kidney) cells. * 
represents p-value of < 0.05. 
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 Viral Infection and Replication in Direct-Infection Pigs 
 Clinical Signs 
All pigs were observed daily for clinical signs of disease. Although pigs did not 
show obvious signs of disease (respiratory distress, lethargy, anorexia), several pigs 
showed fever defined as temperature of 104⁰C and higher. This fever lasted 1-3 days 
between 2- and 5-dpi and included four pigs from the eH1N2 group, five pigs from the 
2+6 rH1N2 group, one pig from the swH1N2v group, and two pigs from the huH1N2v 
group.  
 Macroscopic Lung Lesions 
All direct-infection pigs showed macroscopic lung lesions indicative of swine 
influenza (Figure 3-13) and lungs were assigned scores as a “percent of the lung with 
lesions”. Pigs inoculated with eH1N2 showed lesions on 13.46% ± 3.58% of lungs at 5-
dpi and 6.57% ± 1.40% of lungs at 7-dpi. Pigs inoculated with 2+6 rH1N2 showed 
lesions on 11.92% ± 2.28% of lungs at 5-dpi and 8.13% ± 4.16% of lungs at 7-dpi. Pigs 
inoculated with swH1N2v showed lesions on 30.76% ± 6.39% of lungs at 5-dpi and 
34.10% ± 5.47% of lungs at 7-dpi. Pigs inoculated with 2+6 rH1N2 showed lesions on 
26.05% ± 5.16% of lungs at 5-dpi and 33.95% ± 5.51% of lungs at 7-dpi. Control pigs 
showed no macroscopic lung lesions and were assigned scores of zero. Overall, the 
swH1N2v and huH1N2v viruses caused significantly more lung lesions in all direct-
infection pigs compared to the eH1N2 and 2+6 rH1N2 viruses (Figure 3-14).
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Figure 3-13 Macroscopic lung lesions from direct-infection pigs at 5-dpi. 
 
Figure 3-13 Macroscopic lung lesions of a single direct-infection pig from each direct-infection group at 5-dpi.
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Figure 3-14 Macroscopic lung lesion scores from direct-infection pigs at 5- and 7-
dpi. 
 
Figure 3-14 Macroscopic lung lesion scores from direct infection pigs at 5- and 7-dpi. 
Lungs were assigned scores by a single, experienced research veterinarian as a “percent 
of lungs with lesions.” A p-value < 0.05 was considered statistically significant. 
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 Microscopic Lung Lesions 
All direct-infection pigs showed microscopic lung lesions indicative of swine 
influenza as described by a veterinary pathologist using histopathology (Figure 3-15). For 
histopathology, scores were assigned to the lung tissues on a scale of 0-3 with 0 being no 
lesion, 1 being mild lesions, 2 being moderate lesions, and 3 being severe lesions (Table 
3-5). Pigs inoculated with eH1N2 showed minimal to complete lack of bronchiolar 
epithelial degeneration and necrosis. A mild alveolar epithelial degeneration and necrosis 
was observed with plugging of alveolar lumen with cellular debris. Lung lesions for this 
group were scored as 0.67 ± 0.29 at 5-dpi and 1.17 ± 0.44 at 7-dpi. Pigs inoculated with 
2+6 rH1N2 showed minimal to mild bronchiolar and alveolar epithelial degeneration and 
necrosis. There was mild interstitial pneumonia characterized by small numbers of 
lymphocytes infiltrating the alveolar septa and perivascular areas. Lung lesions for this 
group were scored as 1.00 ± 0.44 at 5-dpi and 0.67 ± 0.17 at 7-dpi. Pigs inoculated with 
swH1N2v showed severe bronchiolar epithelial necrosis and moderate numbers of 
neutrophils were present in the bronchiolar and alveolar lumen. Lung lesions for this 
group were scored as 2.17 ± 0.44 at 5-dpi and 2.17 ± 0.44 at 7-dpi. Pigs inoculated with 
huH1N2v showed moderate to severe bronchiolar epithelial degeneration and necrosis 
with infiltration of neutrophils into the alveolar septa and alveolar and bronchiolar lumen. 
Lung lesions for this group were scored as 2.50 ± 0.29 at 5-dpi and 2.18 ± 0.44 at 7-dpi. 
Overall, both the swH1N2v and huH1N2v viruses caused significantly more severe 
lesions than the eH1N2 and 2+6 rH1N2 viruses (Figure 3-16).  
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Figure 3-15 Microscopic lung lesions from direct-infection pigs at 5-dpi. 
 
Figure 3-15. Microscopic lung sections from direct-infection pigs infected at 5-dpi. The bronchioles are lined by normal cuboidal epithelium 
(arrow) and the alveoli are clear (asterisk) in the control group. In eH1N2, there was minimal to complete lack of bronchiolar epithelial 
degeneration and necrosis. A mild alveolar epithelial degeneration and necrosis was observed with plugging of alveolar lumen with cellular 
debris (asterisk). In 2+6 rH1N2, there was minimal to mild bronchiolar and alveolar epithelial degeneration and necrosis (arrows). There was 
mild interstitial pneumonia characterized by small numbers of lymphocytes infiltrating the alveolar septa and perivascular areas (asterisk). In 
contrast, swH1N2v caused severe bronchiolar epithelial necrosis (arrow). Moderate numbers of neutrophils were present in the bronchiolar 
and alveolar lumen (asterisk). ThehuH1N2v also caused moderate to severe bronchiolar epithelial degeneration and necrosis (arrow) with 
infiltration of neutrophils into the alveolar septa and alveolar and bronchiolar lumen (asterisk). Scale bar is 50 µm in all the photographs.
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Figure 3-16 Microscopic lung lesion scores from direct-infection pigs at 5- and 7-dpi. 
 
Figure 3-16 Microscopic lung lesion scores from direct-infection pigs at 5- and 7-days 
post infection. Lung lobes were collected and fixed in 10% formalin during necropsy 
before staining with Haemotoxylin and eosin for histopathological examination. Anti-
influenza A monoclonal antibody against NP was used for immunohistochemistry 
staining. Lung samples were examined blindly by a veterinary pathologist and scored on 
a scale of 0-3 based on severity of bronchial epithelial injury. 
65 
Table 3-5 Histopathology scoring guide. 
 
Table 3-5 Scoring guide used for histopathological examination of pigs’ lungs. 
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 Viral Replication in Pigs’ Lungs 
All viruses replicated efficiently in direct-infection pigs’ lungs as measured by 
viral titers from BALF samples. Pigs inoculated with eH1N2 had an average viral titer of 
4.50 ± 1.22 detected from pigs necropsied at 5-dpi while no virus was detected at 7-dpi. 
Pigs inoculated with 2+6 rH1N2 had an average viral titer of 4.97 ± 0.37 detected from 
pigs necropsied at 5-dpi while no virus was detected at 7-dpi. Pigs inoculated with 
swH1N2v had an average viral titer of 6.23 ± 0.15 detected from pigs necropsied at 5-dpi 
while no virus was detected at 7-dpi. Pigs inoculated with huH1N2v had an average viral 
titer of 4.70 ± 0.00 detected from 2/3 pigs necropsied at 5-dpi while no virus was detected 
at 7-dpi. Overall, viral titers from BALF samples of pigs inoculated with the swH1N2v 
virus were significantly higher than those from pigs inoculated with the 2+6 rH1N2 and 
huH1N2v viruses (Figure 3-17). 
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Figure 3-17 Viral titers from BALF samples of direct-infection pigs at 5- and 7-dpi. 
 
Figure 3-17 Viral titers from BALF samples of direct-infection pigs. Samples were 
titrated in quadruplicate using 96-well plates of confluent MDCK cells. Serial dilutions 
for each sample were completed from 10-1 to 10-8 using infecting MEM and then 100 µl 
of each dilution was added to MEM-washed confluent MDCK cells in each well. Cells 
were incubated at 37⁰C with 5.0% CO2 and evaluated for CPE at 24- and 48-hpi. At 72-
hpi, plates were fixed in methanol and immunocytochemically stained with a monoclonal 




 Viral Shedding from Pigs 
All viruses shed efficiently from nasal cavities of direct-infection pigs as detected 
by viral titers in nasal swab samples. In pigs inoculated with eH1N2, an average viral 
titer of 3.93 ± 0.14 was detected in 4/6 pigs at 3-dpi. By 5-dpi, an average viral titer of 
3.82 ± 0.30 was detected in 6/6 pigs; however, no virus was detected at 7-dpi. In pigs 
inoculated with 2+6 rH1N2, an average viral titer of 4.20 ± 0.33 was detected in 5/6 pigs 
at 3-dpi. By 5-dpi, an average viral titer of 4.80 ± 0.35 was detected in 6/6 pigs. At 7-dpi, 
an average viral titer of 2.95 ± 0.25 was detected in 2/3 pigs. In pigs inoculated with 
swH1N2v, an average viral titer of 5.27 ± 0.29 was detected in 6/6 pigs at 3 dpi. By 5-
dpi, an average viral titers of 4.73 ± 0.37 was detected in 6/6 pigs; however, no virus was 
detected at 7-dpi. In pigs inoculated with huH1N2v, an average viral titer of 3.24 ± 0.15 
was detected in 5/6 pigs at 3-dpi. By 5-dpi, an average viral titer of 4.03 ± 0.22 was 
detected in 6/6 pigs; however, no virus was detected at 7-dpi (Figure 3-18).  
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Figure 3-18 Viral titers from nasal swab samples of direct-infection pigs at 3-, 5-, 
and 7-dpi. 
 
Figure 3-18 Viral titers from nasal swab samples of direct-infection pigs at 3-, 5-, and 7-
dpi. Samples were titrated in quadruplicate using 96-well plates of confluent MDCK 
cells. Serial dilutions for each sample were completed from 10-1 to 10-8 using infecting 
MEM and then 100 µl of each dilution was added to MEM-washed confluent MDCK 
cells in each well. Cells were incubated at 37⁰C with 5.0% CO2 and evaluated for CPE at 
24- and 48-hpi. At 72-hpi, plates were fixed in methanol and immunocytochemically 
stained with a monoclonal antibody specific to influenza NP. A p-value of < 0.05 was 
considered statistically significant. 
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 Viral Transmission to Contact-Exposure Pigs 
 Clinical Signs 
All pigs were observed daily for clinical signs of disease. Although pigs did not 
show obvious signs of disease (respiratory distress, lethargy, anorexia), several pigs 
showed fever defined as a temperatures of 104⁰C and higher. This fever lasted 1-2 days 
between 2- and 5-dpc and included two pigs from the eH1N2 group, three pigs from the 
2+6 rH1N2 group, one pig from the swH1N2v group, and two pigs from the huH1N2v 
group.  
 Macroscopic Lung Lesions 
Several contact-exposure pigs showed macroscopic lung lesions indicative of 
swine influenza (Figure 3-19) and lungs were assigned scores as a “percent of the lung 
with lesions” by  a single, experienced research veterinarian.  Only 2/4 pigs comingled 
with the eH1N2 direct-infection pigs showed lesions on 4.69% ± 0.82% of lungs at 5-
dpc. Also, only 3/4 pigs comingled with 2+6 rH1N2 direct-infection pigs showed lesions 
on 3.22% ± 0.36% of lungs at 5-dpc. In contrast, 4/4 animals pigs comingled with 
swH1N2v direct-infection  pigs showed lesions on 7.44% ± 1.98% of lungs at 5-dpc. 
Similarly, 4/4 pigs comingled with huH1N2v direct-infection pigs showed lesions on 
4.29% ± 0.457% of lungs at 5-dpc. Overall, 100% of pigs exposed to the swH1N2v and 
huH1N2v direct-infection pigs showed lesions compared with 50% and 75% of pigs 
exposed to the eH1N2 and 2+6 rH1N2 direct-infection pigs, respectively. 
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Figure 3-19 Macroscopic lung lesions from contact-exposure pigs at 5-dpc. 
 
Figure 3-19 Macroscopic lung lesions from contact-exposure pigs at 5-dpc. Lungs were 
assigned scores by a single, experienced research veterinarian as a “percent of lungs with 
lesions.” A p-value < 0.05 was considered statistically significant. 
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 Microscopic Lung Lesions 
All contact-exposure pigs showed microscopic lung lesions indicative of swine 
influenza as described by a veterinary pathologist using histopathology. For 
histopathology, scores were assigned to the lung tissues on a scale of 0-3 with 0 being no 
lesion, 1 being mild lesions, 2 being moderate lesions, and 3 being severe lesion. Pigs 
comingled with eH1N2 direct-infection pigs showed minimal to complete lack of 
bronchiolar epithelial degeneration and necrosis. Lung lesions for this group were scored 
as 0.05 ± 0.14 at 5-dpc. Pigs comingled with 2+6 rH1N2 direct-infection pigs showed 
minimal to complete lack of bronchiolar epithelial degeneration and necrosis. Lung 
lesions for this group were scored as 0.25 ± 0.20 at 5-dpc. Pigs comingled with swH1N2v 
direct-infection pigs showed mild to moderate bronchiolar epithelial necrosis and 
moderate numbers of neutrophils were present in the bronchiolar and alveolar lumen. 
Lung lesions for this group were scored as 1.15 ± 0.13 at 5-dpc. Pigs comingled with 
huH1N2v direct-infection pigs showed mild to moderate bronchiolar epithelial 
degeneration and necrosis. Lung lesions for this group were scored as 0.89 ± 0.13 at 5-
dpc. Overall, pigs exposed to the swH1N2v and huH1N2v direct-infection pigs showed 
significantly more severe lesions when compared to the pigs exposed to the 2+6 rH1N2 
direct-infection pigs (Figure 3-20). 
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Figure 3-20 Microscopic lung lesions from contact-exposure pigs at 5-dpc. 
 
Figure 3-20 Microscopic lung lesions from contact-exposure pigs at 5-dpc. Lung lobes 
were collected and fixed in 10% formalin during necropsy before staining with 
Haemotoxylin and eosin for histopathological examination. Anti-influenza A monoclonal 
antibody against NP was used for immunohistochemistry staining. Lung samples were 
examined blindly by a veterinary pathologist and scored on a scale of 0-3 based on 
severity of bronchial epithelial injury. 
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 Viral Replication in Pigs’ Lungs 
All viruses replicated efficiently in contact-exposure pigs’ lungs as measured by 
viral titers from BALF samples. Pigs comingled with eH1N2 direct-infection pigs had an 
average viral titer of 4.35 ± 0.27 detected from pigs necropsied at 5-dpc. Pigs comingled 
with 2+6 rH1N2 direct-infection pigs had an average viral titer of 4.83 ± 0.38 detected 
from 3/4 pigs necropsied at 5-dpc. Pigs comingled with swH1N2vdirect-infection pigs 
had an average viral titer of 5.90 ± 0.06 detected from pigs necropsied at 5-dpc. Pigs 
comingled with huH1N2v direct-infection pigs had an average viral titer of 4.13 ± 0.56 
detected from pigs necropsied at 5-dpc. Overall, pigs exposed to the swH1N2v direct-
infection pigs had significantly higher viral titers in BALF compared with pigs exposed 
to the eH1N2 and huH1N2v direct-infection pigs (Figure 3-21). 
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Figure 3-21 Viral titers from BALF samples of contact-exposure pigs at 5-dpc. 
 
Figure 3-21 Viral titers from BALF samples of contact-exposure pigs at 5-dpc. Samples 
were titrated in quadruplicate using 96-well plates of confluent MDCK cells. Serial 
dilutions for each sample were completed from 10-1 to 10-8 using infecting MEM and then 
100 µl of each dilution was added to MEM-washed confluent MDCK cells in each well. 
Cells were incubated at 37⁰C with 5.0% CO2 and evaluated for CPE at 24- and 48-hpi. At 
72-hpi, plates were fixed in methanol and immunocytochemically stained with a 




 Viral Shedding from Pigs 
Viruses shed efficiently from nasal cavities of contact-exposure pigs comingled 
with eH1N2-, 2+6 rH1N2-, and swH1N2v-direct-infection pigs as detected by viral titers 
in nasal swab samples. In pigs comingled with eH1N2 direct-infection pigs, viral titers of 
5.98 ± 0.42 was detected in 4/4 pigs at 3-dpc while viral titers of 3.00 ± 0.24 was detected 
in 4/4 pigs at 5-dpc. In pigs comingled with 2+6 rH1N2 direct-infection pigs, viral titers 
of 4.58 ± 0.77 was detected in 4/4 pigs at 3-dpc while viral titers of 3.08 ± 0.22 was 
detected in 4/4 pigs at 5-dpc. In pigs comingled with swH1N2v direct-infection pigs, a 
viral titer of 3.70 was detected from 1/4 pigs as early as 1-dpc. An average viral titer of 
5.75 ± 0.17 was detected in 4/4 pigs at 3-dpc while an average viral titer of 3.88 ± 0.55 
was detected in 4/4 pigs at 5-dpc. However, no virus was detected in nasal swab samples 
of pigs comingled with huH1N2v direct-infection pigs (Figure 3-22). 
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Figure 3-22 Viral titers from nasal swab samples of contact-exposure pigs at 1-, 3-, 
and 5-dpc. 
 
Figure 3-22 Viral titers from nasal swab samples of contact-exposure pigs at 3- and 5-
dpc. Samples were titrated in quadruplicate using 96-well plates of confluent MDCK 
cells. Serial dilutions for each sample were completed from 10-1 to 10-8 using infecting 
MEM and then 100 µl of each dilution was added to MEM-washed confluent MDCK 
cells in each well. Cells were incubated at 37⁰C with 5.0% CO2 and evaluated for CPE at 
24- and 48-hpi. At 72-hpi, plates were fixed in methanol and immunocytochemically 
stained with a monoclonal antibody specific to influenza NP. A p-value of < 0.05 was 
considered statistically significant. 
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 One-step real-time RT-PCR for pH1N1 M gene in swH1N2v and huH1N2v 
contact-exposure pigs 
Nasal swabs collected from contact-exposure pigs in the swH1N2v and huH1N2v 
groups at 1-dpc were all found to be negative with Ct values greater than the cutoff value 
of ‘35’. At 5-dpc, 4/4 (100%) of the pigs exposed to the swH1N2v virus were positive 
with Ct values ranging from 26.45-34.59 (x̄ = 31.67) while only 3/4 (75%) of the pigs 
exposed to the huH1N2v virus were positive with Ct values ranging from 31.56-33.15 9 
(x̄ = 32.26, excluding the negative sample). By 5-dpc, 4/4 (100%) of the pigs exposed to 
the swH1N2v virus were positive with Ct values ranging from 22.34-26.29 (x̄ = 25.44). 
Similarly, 4/4 (100%) of the pigs exposed to the huH1N2v virus were positive, although 
with significantly higher Ct values ranging from 31.72-33.50 (x̄ = 33.01) (Table 3-6). 
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Table 3-6 Ct values for one-step real-time RT-PCR of nasal swab samples from 
swH1N2v and huH1N2v contact-exposure pigs. 
 
Sample ID 1-dpc 3-dpc 5-dpc 
Pig #33 – swH1N2v 35.07 26.45 25.90 
Pig #34 – swH1N2v 37.88 32.68 24.94 
Pig #35 – swH1N2v 36.71 32.96 24.62 
Pig #36 – swH1N2v 38.54 34.59 26.29 
Pig #37 – huH1N2v 36.22 31.56 31.72 
Pig #38 – huH1N2v 37.07 33.15 33.31 
Pig #39 – huH1N2v 35.86 32.09 33.50 
Pig #40 – huH1N2v 38.04 0.00 33.60 
Positive control 22.39 22.56 22.34 
Positive control 21.99 23.06 21.09 
Negative-control Pig 37.75 36.87 35.73 
Negative-control Pig 39.16 37.59 35.01 
Table 3-6 Ct values for each nasal swab sample from pigs exposed to swH1N2v and 
huH1N2v at 1-, 3-, and 5-dpc. Cutoff for this assay was set at 35 threshold cycles (Ct = 
35). A total of 8 µl from a known pH1N1 virus was used as a positive control and 8 µl of 
sample template from a negative-control pig was used as a negative control. 
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Chapter 4 - Discussion and Conclusions 
The ecology of North American SIVs has become increasingly diversified in 
recent years. Prior to 1998, most cases of swine influenza in the US was caused by an 
H1N1 virus known as “classical swine” 122. In 1998 a novel TR H3N2 virus emerged in 
North American swine herds. Reassortment of this TR H3N2 virus with H1N1 viruses 
resulted in the generation of another subtype, the H1N2 virus 116. Introduction of the 2009 
pH1N1 into swine herds has further diversified the ecology and led to the generation of 
numerous reassortant SIVs, all of which contain the pH1N1 M gene based on 
surveillance. 
From December 2005 – November 2010, there were more than 300 human 
infections with SIVs in the US including H1N1v, H1N2v, and H3N2v viruses 151. 
According to the CDC, in 2011 an H3N2v virus with pH1N1 M gene and the remaining 
genes from endemic H3N2 SIVs emerged and caused 12 human infections (mostly in 
children) in Indiana, Maine, Pennsylvania, Iowa, Utah and West Virginia. Also in 2011, 
an H1N2v virus with pH1N1 M gene infected a child at a state fair. There were 12 more 
confirmed cases of humans infected with H3N2v viruses in 2011 and an alarming 309 
cases in 2012 152,153. Fortunately, to date these human infections with variant viruses have 
shown little to no human-to-human transmission. 
Based on our own passive surveillance of Kansas swine herds from 2010-2013, 
we have identified 18 H1N1 SIVs, 22 H3N2 SIVs, and 25 H1N2 SIVs. Preliminary 
sequencing of the HA, NA, and M genes of all viruses revealed a number of reassortant 
viruses with genes from pH1N1 including three H1N1 viruses, 11 H3N2 viruses, and 16 
H1N2 viruses. Full genome sequencing revealed that a number of these reassortant 
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viruses possess only the M gene from pH1N1 including 2/3 of the H1N1 viruses and 
12/16 of the H1N2 viruses. This suggests that this may be a favorable constellation and 
may become established in US swine herds.  
In this study, three swine isolates and one human isolate were characterized in 
vitro and identified as H1N2 SIVs: two variant viruses (one swine and one human) with 
only M gene from pH1N1, one reassortant virus with PB2, PB1, PA, NP, M, and NS 
genes from pH1N1, and one endemic virus with no genes from pH1N1. The results show 
that all viruses replicated efficiently in vitro, growing to significant titers in porcine, 
human, and canine cell lines. Notably, the reassortant and variant viruses with genes from 
pH1N1 grew to significantly higher titers than the endemic virus at various time points in 
all three cell lines. Additionally, both variant viruses formed significantly larger plaques 
than the reassortant and endemic viruses. Taken together, one should expect the viruses 
with pH1N1 M gene to replicate more efficiently in pigs and the variant viruses to be 
more pathogenic. 
Although no obvious signs of influenza were observed in pigs, all viruses caused 
a similar degree of fever in both direct-infection and contact-exposure pigs. Both variant 
viruses caused significantly more severe macroscopic and microscopic lung lesions in 
direct-infection animals than the other two viruses. This trend was also observed in the 
microscopic lung lesions of contact-exposure animals. While the severity of macroscopic 
lung lesions was less pronounced in contact-exposure animals, it should be noted that 
both variant viruses caused lesions in 100% of these animals compared with the endemic 
and reassortant viruses which caused lesions in only 50 – 75% of these animals, 
respectively.  
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The swine variant virus showed enhanced replication and pig-to-pig 
transmissibility compared to the other three viruses. BALF samples show that all viruses 
are able to replicate efficiently in the lower respiratory tract where alpha 2, 3 N-linked 
sialic acids are present; however, the swine variant grew to higher titers in BALF samples 
of both direct-infection and contact-exposure pigs. Nasal swab samples of direct-
infection pigs show that all viruses are capable of replicating in the upper respiratory 
tracts of pigs where alpha 2, 6 N-linked sialic acids are present. The swine variant virus 
seems able to replicate more efficiently than the other three viruses as it was shed in 
highest titers and was the only group in which 100% of direct-infection animals were 
shedding at 3-dpi. In contrast, the human variant was only detected in BALF samples 
from 67% of direct-infection pigs at 5-dpi. Additionally, it was only detected at low titers 
from the nasal swabs of contact-exposure pigs using one-step real-time RT-PCR specific 
for the pH1N1 M gene suggesting that it may be incapable of sustained pig-to-pig 
transmission. 
The data from this pig study highlights differences from a previous study in pigs 
involving H3N2v viruses published by Kim, Seong-Hee et. al. 163. In that study, fever 
was accompanied by nasal discharge from all pigs which progressed from mucoserous to 
mucopurulent while no nasal discharge was observed in the current study. They also 
found higher copies of RNA in contact-exposure pigs compared with direct-infection pigs 
while no significant difference was observed in this study. Moreover, their study found 
high RNA copies in BALF samples for as long as 14 dpi (our study concluded at 7 dpi) 
suggesting that the virus may not have been cleared; however, in the current study, all 
virus appeared to have been cleared from the lungs by 7 dpi. Moreover, the viruses in that 
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study only caused pathogenesis similar to that of typical SIVs while the variant viruses in 
the current study were far more pathogenic than typical SIVs and caused significantly 
more severe lung lesions than the other two viruses. This demonstrates differences in 
behavior between the H3N2v and H1N2v viruses, further supporting the importance of 
studying the H1N2v viruses. 
The apparent increased transmissibility and pathogenicity of the swH1N2v is 
most likely due to a number of factors. Given the roles of HA and NA with virus 
attachment, the immune response, and viral budding, it is interesting that the HA and NA 
molecules of swH1N2v varied significantly from the other three viruses. As 
aforementioned, there are 23 unique amino acids in the HA molecule of swH1N2v 
compared with the other three viruses. Although the PIRs of the HA molecules are highly 
similar between the viruses, swH1N2v possessed one difference from the other three 
viruses, P187S. Similarly, the putative antigenic sites of the HA molecules were similar 
with one exception in swH1N2v, N183D. It is possible that either of these differences 
enhances the virus’s ability to attach to host cells. In contrast, the HA molecule of 
huH1N2v possessed only two unique amino acid differences from the other three viruses: 
E164V and K184R. The NA molecule of swH1N2v possesses 21 unique amino acids 
compared to the other three viruses while huH1N2v possesses only three: D42N, P126T, 
and T267K. To our knowledge, changes in these amino acids of the HA and NA 
molecules have not been previously published and may be targets for transmissibility 
studies. 
As expected, few amino acid differences were identified between the M1 and M2 
molecules of the viruses. The huH1N2v possessed one unique amino acid in its M1 
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molecule, S30N, while none were identified in swH1N2v. Interestingly, amino acid 
residue 30 is thought to play a role in determining morphology of the virus and its 
possible that a change in this amino acid can alter the morphology from spherical to more 
filamentous, affecting its transmissibility. Analysis of the M2 molecules revealed only 
one unique amino acid difference for each variant virus: D24N in swH1N2v and P25S in 
huH1N2v. These sites have not been investigated and may serve a functional importance 
in the transmissibility and replication of these viruses. 
Analysis of the NS1 molecules revealed only one unique amino acid to swH1N2v, 
N139S, while huH1N2v possesses five unique amino acids: G45R, G51S, V84I, M124I, 
and V178I. Given the role of NS1 as a host antiviral antagonist, it is possible that these 
changes in huH1N2v affect the virus’s ability to overcome the host antiviral response. 
This might explain the decreased titers observed in BALF and nasal swab samples 
collected. It might also explain why BALF samples from only 2/3 pigs collected at 5-dpi 
and nasal swab samples from only 5/6 animals collected at 3-dpi were positive for virus. 
In contrast, only one unique amino acid is present in the NS2 of huH1N2v compared with 
the other three viruses: I19T. The NP molecules of both variant viruses were highly 
homologous with only one unique amino acid residue identified in each: K400R in 
swH1N2v and N125S in huH1N2v.  
Our results show that the swH1N2v virus is more pathogenic and transmissible in 
pigs when compared to the endemic and novel reassortant H1N2 SIVs. Furthermore, our 
surveillance data revealed that the H1N2v is the predominant genotype of H1N2 SIVs 
circulating in Kansas swine herds suggesting that they might become established in pigs 
causing more challenges for the pig industry. Taken together, these results warrant the 
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continued surveillance and analysis of SIVs. In Kansas alone, there are more than 1,500 
hog farms with 3.1 million hogs that account for 95% of the state’s pork supply and 2.7% 
of the nation’s pork supply (www.nationalhogfarmer.com). Should a more virulent 
variant virus emerge it could result in disaster for local hog farmers and the nation’s food 
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